Gerard Rivera

About Gerard Rivera

Billions in copay assistance dollars meant for patients never reach them. And no one has had a solution. Until now.I’m the Co-Founder and CEO of RIS Rx, where we’re helping solve one of pharma’s biggest challenges: gross-to-net revenue leakage in patient affordability programs.From running high-volume Big Box Retail stores to owning my own pharmacy, I saw firsthand how much waste and confusion live in the gap between manufacturers and the point of care. Pharma teams are trying to help patients, but the system makes it hard to see where money and access are truly being lost.That’s why we founded RIS Rx, with a simple but urgent mission: to make sure the billions manufacturers invest in affordability and access actually reach the patients who need it most.The challenge we tackle is what I call GTN Blind Spots, when manufacturers can see leakage KPIs in dashboards and reports, but can’t pinpoint the sources fast enough to stop it. Dollars meant for patients disappear through intermediaries, and by the time it’s identified, it’s too late.RIS Rx changes that.As a pharmacist and operator who’s worked across retail, specialty, and independent settings, I built RIS Rx to close the gap between patient intent and patient support, and I’m energized by the opportunity ahead of us.If you’re passionate about transforming how pharma delivers value and access, let’s connect.

Experience

1. Adjunct Faculty

   Loma Linda University

   Jan 2014 — Present

Education

• UC Irvine

  Bachelor of Science (BS), Biology, General

  2002 — 2006

• Loma Linda University

  Doctor of Pharmacy (PharmD), Pharmacy

  2007 — 2011